HR 124

This bill aims to raise awareness about renal medullary carcinoma, a rare kidney cancer, among individuals with sickle cell disease who receive Medicaid coverage. It does this by modifying the existing Medicaid rules to encourage states to provide educational materials and information about this disease. Specifically, the bill adds ‘renal medullary carcinoma’ to the list of conditions that Medicaid will cover education for. This will help ensure those at risk receive crucial information to potentially improve their health outcomes.